Mark Thomas


  • The University of Western Australia (M570), 35 Stirling Highway,

    6009 Perth


  • 330 Citations
  • 9 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mark Thomas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Kidney Medicine & Life Sciences
Brachial Artery Medicine & Life Sciences
Glomerular Filtration Rate Medicine & Life Sciences
Dilatation Medicine & Life Sciences
Albuminuria Medicine & Life Sciences
Galactosidases Medicine & Life Sciences
Fabry Disease Medicine & Life Sciences
Hypoaldosteronism Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2018

  • 330 Citations
  • 9 h-Index
  • 18 Article
  • 3 Review article
  • 2 Chapter
  • 1 Letter
2 Citations (Scopus)

Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study

Hughes, J. T., Maple-Brown, L. J., Thomas, M., Lawton, P. D., Sinha, A., Cass, A., Barzi, F., Jones, G. R. D., Jerums, G., MacIsaac, R. J., O'Dea, K. & Hoy, W. E., 1 Jan 2018, In : Nephrology. 23, 1, p. 37-45 9 p.

Research output: Contribution to journalArticle

Glomerular Filtration Rate
Waist-Hip Ratio
3 Citations (Scopus)

Bilirubin concentration is positively associated with haemoglobin concentration and inversely associated with albumin to creatinine ratio among Indigenous Australians: eGFR Study

Hughes, J. T., Barzi, F., Hoy, W. E., Jones, G. R. D., Rathnayake, G., Majoni, S. W., Thomas, M. A. B., Sinha, A., Cass, A., MacIsaac, R. J., O'Dea, K. & Maple-Brown, L. J., Dec 2017, In : Clinical Biochemistry. 50, 18, p. 1040-1047 8 p.

Research output: Contribution to journalArticle

Mesorhizobium peritonitis: The first reported case

Krishnan, A., Raby, E., Puttagunta, H., Leung, M. & Thomas, M., 1 Jan 2017, In : Nephrology. 22, 1, p. 96 1 p.

Research output: Contribution to journalLetter

77 Citations (Scopus)

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Hughes, D. A., Nicholls, K., Shankar, S. P., Sunder-Plassmann, G., Koeller, D., Nedd, K., Vockley, G., Hamazaki, T., Lachmann, R., Ohashi, T., Olivotto, I., Sakai, N., Deegan, P., Dimmock, D., Eyskens, F., Germain, D. P., Goker-Alpan, O., Hachulla, E., Jovanovic, A., Lourenco, C. M. & 18 othersNarita, I., Thomas, M., Wilcox, W. R., Bichet, D. G., Schiffmann, R., Ludington, E., Viereck, C., Kirk, J., Yu, J., Johnson, F., Boudes, P., Benjamin, E. R., Lockhart, D. J., Barlow, C., Skuban, N., Castelli, J. P., Barth, J. & Feldt-Rasmussen, U., 1 Apr 2017, In : Journal of Medical Genetics. 54, 4, p. 288-296 9 p.

Research output: Contribution to journalArticle

Open Access
Enzyme Replacement Therapy
Fabry Disease
3 Citations (Scopus)

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Prosser, H. C., Gregory, C., Hering, D., Hillis, G. S., Perry, G., Rosman, J., Schultz, C., Thomas, M., Watts, G. F. & Schlaich, M. P., 1 Apr 2017, In : Current Hypertension Reports. 19, 4, 30.

Research output: Contribution to journalReview article

Drug Therapy
Adrenergic Antagonists
Antihypertensive Agents
Pharmaceutical Preparations